Adaptive response towards adriamycin in vitro: Circumvention with verapamil

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 431, Issue 1, 1999, Pages 25-30

  Anuszewska, Elzbieta Lidia ^a   Koziorowska, Jadwiga Hanna ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Adaptive response; Adriamycin; Multidrug resistance

Indexed keywords

DOXORUBICIN; VERAPAMIL;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCIUM CHANNEL BLOCKERS; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; INHIBITORY CONCENTRATION 50; MELANOMA; METHOTREXATE; TUMOR CELLS, CULTURED; VERAPAMIL; VINBLASTINE;

EID: 0033374131     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00153-0     Document Type: Article

References (23)

1. Montaudon D., Pourquier Ph., Denois F., De Tinguy-Moreaud E., Lagarde Ph. Differential stabilization of topoizomerase-II-DNA cleavable complex by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells. Eur. J. Biochem. 245:1997;307-315.
2. Snow K., Judd W. Characterisation of adriamycin and amsacrine-resistant human leukemia T cell line. Br. J. Cancer. 64:1991;17-28.
3. Twentyman P.R., Fox N.E., Wright K.A., Bleehen N.H. Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells. Br. J. Cancer. 53:1986;529-537.
4. 2 on adriamycin-induced cytotoxicity in vitro. Arch. Immunol. Ther. Exp. 42:1994;281-286.
5. Anuszewska E.L., Gruber B.M., Koziorowska J.H. Studies on adaptation to adriamycin in cells pretreated with hydrogen peroxide. Biochem. Pharmacol. 54:1997;597-603.
6. Anuszewska E.L., Koziorowska J.H. Capability of adriamycin and busulfan to induce adaptive response in vitro. Arch. Immunol. Ther. Exp. 47:1999;78-82.
7. Beck W.T. The cell biology of multiple drug resistance. Biochem. Pharmacol. 36:1987;2879-2887.
8. Bradley G., Juranka P.F., Ling V. Mechanism of multidrug resistance. Biochim. Biophys. Acta. 948:1988;87-128.
9. Finlay G.J., Baguley B.C., Snow K., Judd W. Multiple patterns of resistance of human leukemia sublines to amsacrine analogues. J. Natl. Cancer Inst. 82:1990;662-667.
10. Siegsmund M.J., Kreukler C., Steidler A., Nebe C.T., Kohrmann K.U., Alken P. Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein. Urol. Res. 25(1):1997;35-41.
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
12. Juliano R.L., Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta. 455:1976;152-162.
13. Seemann O., Muscheck M., Siegsmund M., Pilch H., Nebe C.T., Rassweiler J., Alken P. Establishment and characterisation of multidrug-resistant human bladder carcinoma cell line RT112/D21. Urol. Res. 22(6):1995;353-360.
14. Takeshida H., Gebhardt M.C., Springfield D.S., Kusuzaki K., Mankin H.J. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines. J. Bone Jt. Surg. 78(3):1996;366-375.
15. Merry S., Fetherston C.A., Kay S.B., Freshney R.I., Plumb J.A. Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil. Br. J. Cancer. 53:1986;129-135.
16. Rogan A.M., Hamilton T.C., Young R.C., Klecker R.W., Ozols R.F. Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science. 224:1984;994-996.
17. Akman S.A., Forest G., Chu F.F., Esworthy R.S., Doroshow J.H. Antioxidant and xenobiotic-metabolizing enzymes gene expression in doxorubicin-resistant MCF-7 breast cancer cells. Cancer Res. 50:1990;397-401.
18. Benchekroun M.N., Pourquier Ph., Schott B., Robert J. Doxorubicin-induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance do doxorubicin. Eur. J. Biochem. 211:1993;141-146.
19. Doroshow J.H., Akman S.A., Esworthy R.S., Chu F.F., Burke T. Doxorubicin resistance conferred by selective enhancement of intracellular glutathione peroxidase or superoxide dismutase content in human MCF-7 breast cancer cells. Free Radical Res. Commun. 12:1991;779-781.
20. Zijlstra J.G., deVries G.E., Mulder N.H. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 47:1987;1780-1784.
21. 1 phase human lymphocytes. Mutat. Res. 265:1992;273-281.
22. Wiese A.G., Pacifici R.E., Davies K.J.A. Transient adaptation to oxidative stress in mammalian cells. Arch. Biochem. Biophys. 318:1995;231-240.
23. Anuszewska E.L., Gruber B.M. Superoxide dismutase and catalase activities in normal and neoplastic cells chronic treated with adriamycin. J. Exp. Clin. Cancer Res. 14:1995;26-27.